Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20240326061366N2Phase 3Completed
Phase 3 trial of diphenhydramine in delirium, agitation and intermittent explosive disorder (IED), sponsored by Yasouj University of Medical Sciences. Started Jul 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20240326061366N2.